LIDOCAINE ACCORD 2% lidocaine hydrochloride 40 mg/2 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 40 mg/2 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 40 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

Lidocaine 4% cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lidocaine 4% cream

colorama pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

LIDOCAINE ACCORD1% lidocaine hydrochloride 200 mg/20 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord1% lidocaine hydrochloride 200 mg/20 ml injection vial

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 200 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LMX 4 TOPICAL ANAESTHETIC CREAM lidocaine (lignocaine) 40 mg/g tubes with dressings Australia - English - Department of Health (Therapeutic Goods Administration)

lmx 4 topical anaesthetic cream lidocaine (lignocaine) 40 mg/g tubes with dressings

dermocosmetica pty ltd - lidocaine, quantity: 40 mg/g - cream - excipient ingredients: hydrogenated lecithin; carbomer 940; propylene glycol; benzyl alcohol; trolamine; cholesterol; polysorbate 80; dl-alpha-tocopheryl acetate; purified water - topical anaesthesia of intact skin prior to superficial skin procedures, including insertion of iv catheters and blood sampling.

LMX 4 TOPICAL ANAESTHETIC CREAM lidocaine (lignocaine) 40 mg/g tube Australia - English - Department of Health (Therapeutic Goods Administration)

lmx 4 topical anaesthetic cream lidocaine (lignocaine) 40 mg/g tube

dermocosmetica pty ltd - lidocaine, quantity: 40 mg/g - cream - excipient ingredients: trolamine; propylene glycol; purified water; dl-alpha-tocopheryl acetate; benzyl alcohol; hydrogenated lecithin; cholesterol; polysorbate 80; carbomer 940 - topical anaesthesia of intact skin prior to superficial skin procedures, including insertion of iv catheters and blood sampling.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 200 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 200 mg/20 ml solution for injection vial

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 40 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 40 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.66 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 20 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 20 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.